A detailed history of Peak6 LLC transactions in Uni Qure N.V. stock. As of the latest transaction made, Peak6 LLC holds 11,100 shares of QURE stock, worth $331,668. This represents 0.0% of its overall portfolio holdings.

Number of Shares
11,100
Previous 112,900 90.17%
Holding current value
$331,668
Previous $1.57 Million 58.87%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 14, 2025

BUY
$10.6 - $18.08 $41,022 - $69,969
3,870 Added 21.28%
22,057 $233,000
Q4 2024

Feb 13, 2025

BUY
$4.54 - $17.73 $82,568 - $322,455
18,187 New
18,187 $321,000

Others Institutions Holding QURE

About uniQure N.V.


  • Ticker QURE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,729,100
  • Market Cap $1.4B
  • Description
  • uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...
More about QURE
Track This Portfolio

Track Peak6 LLC Portfolio

Follow Peak6 LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Peak6 LLC, based on Form 13F filings with the SEC.

News

Stay updated on Peak6 LLC with notifications on news.